Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0934
+0.0092 (10.93%)
Jul 28, 2026, 2:15 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 114.65 million as of July 28, 2026. Its market cap has decreased by -22.17% in one year.
Market Cap
114.65M
Enterprise Value
122.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 114.65M, a decrease of -85.06%. That is a compound annual growth rate of -43.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 114.65M | - |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.44T |
| Genmab | 117.14B |
| Coloplast | 94.59B |
| Demant | 58.88B |
| Gubra | 5.81B |
| BioPorto | 579.28M |
| Scandinavian Medical Solutions | 85.09M |
| ViroGates | 84.00M |